The Menopause Misinformation Problem with Amanda Thebe
Impossibile aggiungere al carrello
Rimozione dalla Lista desideri non riuscita.
Non è stato possibile aggiungere il titolo alla Libreria
Non è stato possibile seguire il Podcast
Esecuzione del comando Non seguire più non riuscita
-
Letto da:
-
Di:
Amanda Thebe is back, and she and Dr. Spencer Nadolsky and Dr. Karl Nadolsky spend this one on something that frustrates all three of them daily: the state of menopause information online.
Amanda has spent nearly a decade as a patient advocate in this space. She watched the conversation go from nobody talking about menopause to the topic being completely saturated, and she makes the case that it didn't just get louder, it got manipulated. Her own experience is a big part of why. She walks through what happened at 42 when she couldn't get out of bed, started falling over, was peeing her pants after two uncomplicated births, and spent two years in the Canadian healthcare system getting scans before a gynecologist finally said the word perimenopause. Her first reaction to hearing it is one of the better moments in the episode.
The part that will stop you is what came next. Amanda tried hormone therapy and it never worked for her. Every formulation, every dose, cycling on and off for four years, with migraines up to 20 days a month and symptoms that got worse instead of better. When she reached out to a doctor she considered the guru in this space for help, the advice she got back was to ask for an elective hysterectomy on a healthy uterus so she could take estrogen alone. That was the moment she realized there was a grift.
From there the conversation covers what hormone therapy is actually indicated for versus what influencers claim, why testosterone is being oversold, the real risks of pellets and unnecessary compounded products, and how venture capital money is reshaping telehealth in ways that put profit ahead of patients. Spencer and Karl also get into what the Women's Health Initiative actually showed and why the pendulum swinging too far the other way created the exact conditions these companies are now exploiting.
It's not an anti-hormone-therapy episode. All three of them agree more women should probably be on it, and that it's first line treatment for the things it treats. The point is that fear sells in both directions, and women deserve accurate information and a real choice.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.